Growth Metrics

Innoviva (INVA) FCF Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 723.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,066.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -318,699.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -318,699.00
Sep 30, 2025 -1.47 Mn
Jun 30, 2025 -415,265.00
Mar 31, 2025 -788,147.00
Sep 30, 2024 -12,691.00
Jun 30, 2024 -720,059.00
Mar 31, 2024 -405,487.00
Sep 30, 2023 7,584.00
Jun 30, 2023 379,505.00
Mar 31, 2023 312,911.00
Sep 30, 2022 1.47 Mn
Jun 30, 2022 410,847.00
Mar 31, 2022 779,742.00
Sep 30, 2021 17,377.00
Jun 30, 2021 716,725.00
Mar 31, 2021 779,467.00
Dec 31, 2020 1.69 Mn
Sep 30, 2020 -534.00
Jun 30, 2020 6,242.00
Mar 31, 2020 2,482.00
Dec 31, 2019 3,977.00
Sep 30, 2019 2,742.00
Jun 30, 2019 4,978.00
Mar 31, 2019 10,892.00
Dec 31, 2018 4,707.00
Sep 30, 2018 7,788.00
Jun 30, 2018 5,670.00
Mar 31, 2018 11,881.00
Dec 31, 2017 13,399.00
Sep 30, 2017 219,862.00
Jun 30, 2017 574,969.00
Mar 31, 2017 676,817.00
Dec 31, 2016 283,450.00
Sep 30, 2016 1.01 Mn
Jun 30, 2016 135,279.00
Mar 31, 2016 247,863.00
Dec 31, 2015 1,057.00
Sep 30, 2015 198,686.00
Jun 30, 2015 671,773.00
Mar 31, 2015 1,021.00
Dec 31, 2014 42,461.00
Sep 30, 2014 -180,922.00
Jun 30, 2014 -541,143.00
Mar 31, 2014 -626,885.00